These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 32207251

  • 1. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
    Elakad O, Lois AM, Schmitz K, Yao S, Hugo S, Lukat L, Hinterthaner M, Danner BC, von Hammerstein-Equord A, Reuter-Jessen K, Schildhaus HU, Ströbel P, Bohnenberger H.
    Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
    [Abstract] [Full Text] [Related]

  • 2. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.
    Zhang L, Yu H, Badzio A, Boyle TA, Schildhaus HU, Lu X, Dziadziuszko R, Jassem J, Varella-Garcia M, Heasley LE, Kowalewski AA, Ellison K, Chen G, Zhou C, Hirsch FR.
    J Thorac Oncol; 2015 Jul; 10(7):1083-90. PubMed ID: 26020126
    [Abstract] [Full Text] [Related]

  • 3. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS, Lee JS, Kim EY, Jung JY, Kim SK, Chang J, Kim DJ, Lee CY, Jung I, Kim JH, Kim HR, Moon YW, Kim HS, Cho BC, Shim HS.
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [Abstract] [Full Text] [Related]

  • 4. Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC).
    Guo Q, Sun Y, Yu S, Bai H, Zhao J, Zhuo M, Wang J.
    Thorac Cancer; 2017 Mar; 8(2):73-79. PubMed ID: 28008744
    [Abstract] [Full Text] [Related]

  • 5. Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.
    Thomas A, Lee JH, Abdullaev Z, Park KS, Pineda M, Saidkhodjaeva L, Miettinen M, Wang Y, Pack SD, Giaccone G.
    J Thorac Oncol; 2014 Apr; 9(4):567-71. PubMed ID: 24736083
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
    Monaco SE, Rodriguez EF, Mahaffey AL, Dacic S.
    Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FGFR1 amplification in squamous cell carcinoma of the lung.
    Heist RS, Mino-Kenudson M, Sequist LV, Tammireddy S, Morrissey L, Christiani DC, Engelman JA, Iafrate AJ.
    J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.
    Clauditz TS, Böttcher A, Hanken H, Borgmann K, Sauter G, Wilczak W, Grob T, Münscher A.
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):53-61. PubMed ID: 29022097
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
    Lim SH, Sun JM, Choi YL, Kim HR, Ahn S, Lee JY, Lee SH, Ahn JS, Park K, Kim JH, Cho BC, Ahn MJ.
    Cancer; 2016 Oct; 122(19):3024-31. PubMed ID: 27315356
    [Abstract] [Full Text] [Related]

  • 18. Expression and prognostic impact of CD49b in human lung cancer.
    Tirilomi A, Elakad O, Yao S, Li Y, Hinterthaner M, Danner BC, Ströbel P, Tirilomis T, Bohnenberger H, von Hammerstein-Equord A.
    Medicine (Baltimore); 2022 Feb 11; 101(6):e28814. PubMed ID: 35147120
    [Abstract] [Full Text] [Related]

  • 19. Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
    Schildhaus HU, Heukamp LC, Merkelbach-Bruse S, Riesner K, Schmitz K, Binot E, Paggen E, Albus K, Schulte W, Ko YD, Schlesinger A, Ansén S, Engel-Riedel W, Brockmann M, Serke M, Gerigk U, Huss S, Göke F, Perner S, Hekmat K, Frank KF, Reiser M, Schnell R, Bos M, Mattonet C, Sos M, Stoelben E, Wolf J, Zander T, Buettner R.
    Mod Pathol; 2012 Nov 11; 25(11):1473-80. PubMed ID: 22684217
    [Abstract] [Full Text] [Related]

  • 20. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K, Kohlhaussen J, Burkhardt L, Simon R, Steurer S, Burdak-Rothkamm S, Jacobsen F, Sauter G, Krech T.
    PLoS One; 2015 Nov 11; 10(11):e0141867. PubMed ID: 26555375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.